29 August 2016

SQS win 22m worth of orders

Ben Jaglom

German software testing concern SQS Software Quality Systems (SQS) has announced a raft of contract wins worth a total of 22 million.

The AIM-quoted concern declared the contract wins will be coming with a deal to provide 'test management, automation and functional testing' to a 'large European logistics company' This contract is said to be worth 10 million over the next two years. Another deal is to provide the same services but to the French operations of a 'global insurance provider' worth 5 million. Its other contracts include wins with 'four leading retail companies' worth a total of 3.3 million, three public sector contracts worth 2.5 million, a contract with a 'multi-national media company' worth 500,000 and a deal with a 'major UK utilities company' costing €300,000.

SQS' chief executive officer Rudolf van Megen enthused that the win 'highlight the compelling value propositions' of SQS' products and services adding that it provides the company with confidence for the expansion of our regional presence and market share.'

Analysts at house broker Arbuthnot held their forecasts. The broker expects pre-tax profits of 11.4 million (EPS: 28.96 cents) on sales of 178.7 million for the year to December 2011. In 2012 it predicts profits of 13.6 million (EPS: 33.6 cents) on revenue of 199.6 million.

Growth Company Investor recommended shares in SQS this January as a buy/hold at 225p and they have since lost 11.3 per cent, currently trading at 199.5p. Though the latest wins have not moved forecasts they are nonetheless encouraging steps. We retain our buy/hold rating.

Tags: Business in Germany, German Technology, Independent software testing, Quality management services

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Retailers getting One View of their customers

One View listed on AIM via a reverse takeover back in March. It has developed software that provides retailers with a combined view of their customers history in both online and in-store shopping channels. This sort of digital engagement is a big opportunity for retailers to boost their sales.

Angle moves into the clinical trial stage

Angle is making good progress with its ‘Parsortix’ system which uses a precision-etched cassette to ‘sieve’ patient blood samples and capture cancerous tumour cells. The first major trial is now underway in ovarian cancer, led by the University of Vienna.

StatPro benefiting from a Revolution

StatPro shares have done well over the last month with the stock market giving the company credit for the growth in its new ‘Revolution’ product.

Tracsis signs key US deal

Transportation software specialist Tracsis has won a significant contract in the US. This looks like it could be a breakthrough which opens up the vast North American railroad market to this Leeds based company.

MedaPhor expands in ultrasound

MedaPhor came to the market two years ago and the £14 million market cap’s shares have done little since. However a couple of recent developments suggest they are worth keeping an eye on.

ScS sees no slowdown in sofas

ScS Group confirms it hasn't seen a slowdown in demand post-Brexit. Momentum has continued since the update in early June, with like-for-like sales order intake of 14.8 per cent for the first financial year ending in July.

More News